A systemic inflammatory response is observed in patients undergoing hemorrhagic shock and sepsis. Here we report increased levels of cold-inducible RNA-binding protein (CIRP) in the blood of individuals admitted to the surgical intensive care unit with hemorrhagic shock. In animal models of hemorrhage and sepsis, CIRP is upregulated in the heart and liver and released into the circulation. In macrophages under hypoxic stress, CIRP translocates from the nucleus to the cytosol and is released. Recombinant CIRP stimulates the release of tumor necrosis factor-a (TNF-a) and HMGB1 from macrophages and induces inflammatory responses and causes tissue injury when injected in vivo. Hemorrhage-induced TNF-a and HMGB1 release and lethality were reduced in CIRP-deficient mice. Blockade of CIRP using antisera to CIRP attenuated inflammatory cytokine release and mortality after hemorrhage and sepsis. The activity of extracellular CIRP is mediated through the Toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD2) complex. Surface plasmon resonance analysis indicated that CIRP binds to the TLR4-MD2 complex, as well as to TLR4 and MD2 individually. In particular, human CIRP amino acid residues 106-125 bind to MD2 with high affinity. Thus, CIRP is a damage-associated molecular pattern molecule that promotes inflammatory responses in shock and sepsis. npg
Thirty-seven million people are admitted to the emergency room with traumatic injury each year, and these injuries are a leading cause of death in the United States 1 . Hemorrhagic shock from loss of blood volume is a major cause of morbidity and mortality after trauma 2 . During fluid resuscitation, excessive amounts of inflammatory cytokines are produced, causing systemic inflammatory response syndrome and multiple organ dysfunction 3 . Sepsis is also associated with systemic inflammatory response syndrome and is frequently observed in the intensive care unit (ICU), with an overall mortality of 30% in the United States 4 . Sepsis was originally defined as severe systemic inflammation that occurs in a host in response to invading pathogens 5 .
Systemic inflammation can be triggered by exogenous pathogenassociated molecular pattern molecules (PAMPs) that are expressed on invading microorganisms during infection or by endogenous damageassociated molecular pattern molecules (DAMPs) that are released from host cells during tissue injury 6, 7 . Both PAMPs and endogenous DAMPs are recognized by immune cells through a group of patternrecognition receptors (PRRs), including TLRs, receptors of advanced glycation end products (RAGEs, also called AGERs), C-type lectin receptors, scavenger receptors and complement receptors [8] [9] [10] . After binding the receptors, several signaling pathways are activated, leading to the production of inflammatory mediators such as cytokines, chemokines and vasoactive peptides 6, 11, 12 . Although the involvement of microbial PAMPs is well supported, an understanding of the role of endogenous molecules in inducing inflammation has just begun to emerge. In recent years, several molecules varying in both structure and intracellular function have been identified as alarmin danger signals in triggering immune responses. Members of this growing alarmin family include HMGB1 (refs. 13,14) , heat shock proteins 15 , uric acid 16 , S100 proteins 17 , histones 18 and mitochondrial DNA 19 .
CIRP belongs to the family of cold shock proteins that respond to cold stresses. Murine and human CIRP are 172-residue (95% identical) nuclear proteins consisting of one N-terminal consensus-sequence RNA-binding domain and one C-terminal glycine-rich domain, and these proteins function as RNA chaperones to facilitate translation ( Supplementary Fig. 1 ) [20] [21] [22] . CIRP is constitutively expressed at low levels in various tissues 20, 23, 24 and is upregulated during mild hypothermia 22 , exposure to ultraviolet (UV) irradiation 25 and hypoxia 26 .
Here we found that extracellular CIRP is an endogenous proinflammatory mediator and DAMP that triggers inflammatory responses during hemorrhagic shock and sepsis.
RESULTS

CIRP levels are increased in hemorrhaged humans and animals
To explore the role of CIRP in clinical conditions, we examined expression of CIRP in sera from ten individuals admitted to the surgical ICU ( Supplementary Table 1 ; five females and five males with an average age of 71 years). The Acute Physiology and Chronic Health Evaluation II (APACHE II) scores for these individuals ranged from 13 to 25, with an average of 19. The average blood sample collection time was 43 h after the onset of shock, which was defined by a clinically documented systolic blood pressure <90 mm Hg either during active hemorrhage or after a traumatic insult. Serum CIRP was readily detectable in all ten individuals regardless of differences in clinical parameters, whereas serum CIRP was barely detectable in healthy volunteers ( Fig. 1a) .
We induced hemorrhagic shock in rats by bleeding animals to a mean arterial pressure of 25-30 mm Hg and maintaining that pressure for 90 min. We then provided fluid resuscitation. Serum CIRP was detectable at 240 min, and serum CIRP levels were significantly elevated at 330 min post shock in hemorrhaged rats ( Fig. 1b) . CIRP protein levels were nonsignificantly increased at 150 and 240 min in the liver and heart, respectively ( Fig. 1b) . CIRP mRNA levels were significantly induced by 4.1-fold and 2.8-fold in the liver and heart, respectively, at 240 min post shock ( Fig. 1c) .
CIRP is released from macrophages exposed to hypoxia Because CIRP was detectable in the serum of both humans and rats after shock, we attempted to determine the mode of CIRP release. Macrophages are a major cell population responsible for the release of inflammatory mediators after injury. We cultured mouse macrophage-like RAW 264.7 cells under hypoxic conditions to mimic conditions occurring during hemorrhagic shock and examined the cellular location of CIRP. CIRP was located primarily in the nucleus during normoxic conditions ( Fig. 1d) . When we subjected cells to 20 h of hypoxia, CIRP expression was detectable in the cytoplasm at 7 h after reoxygenation and was markedly increased at 24 h after reoxygenation, as determined by biochemical fractionation (Fig. 1d ). By using a molecular biology approach, we observed that GFP-CIRP expression (green fluorescence) in the nucleus overlapped with Hoechst staining in RAW 264.7 cells under normoxia ( Fig. 1e) , whereas GFP alone was expressed throughout the cell (Supplementary Fig. 2 ). However, when we subjected cells to hypoxia, we observed GFP-CIRP expression in the nucleus and cytoplasm at 4 h after reoxygenation ( Fig. 1e) .
We then examined release of cytoplasmic CIRP into the extracellular space. In the conditioned medium of RAW 264.7 cells, CIRP was undetectable in normoxia but was released at 24 h after reoxygenation, as determined by western blotting (Fig. 1f ). Furthermore, intracellular CIRP protein levels increased by 2.8-fold as compared to normoxia immediately after hypoxia and by 4.3-fold after 7 h of reoxygenation but were then reduced after 24 h of reoxygenation, potentially because of the release of CIRP into the medium (Fig. 1f,g) . CIRP release was not attributable to necrosis, as there was no change in lactate dehydrogenase activity and no detectable intracellular BCL2-associated X protein (BAX) in the conditioned medium after hypoxia (data not shown).
The CIRP protein sequence does not contain a secretion leader signal, suggesting that its secretion should not be mediated through npg the classical (endoplasmic reticulum-Golgi dependent) pathway 27 . To identify a potential mechanism of active CIRP release, we conducted biochemical fractionation to isolate the lysosomal compartment of RAW 264.7 cells undergoing hypoxia. During normoxia, CIRP protein was not detectable in lysosomes, but it colocalized with cathepsin D, a protein maker of lysosomes, at 24 h after reoxygenation from hypoxia ( Fig. 1h ), suggesting that CIRP may be released by lysosomal secretion.
Recombinant CIRP induces inflammatory responses
To address whether extracellular CIRP could function as an inflammatory mediator, we expressed and purified recombinant murine CIRP (rmCIRP) using a bacterial expression system with more than 97% purity ( Supplementary Fig. 3a,b ). We conducted a Triton X-114 extraction procedure to remove lipopolysaccharide (LPS) 28 from the purified rmCIRP. We detected a residual ~10 pg of LPS per µg of CIRP by the Limulus amebocyte lysate assay, which was comparable to that described in other identified endogenous DAMPs expressed and purified from bacteria 29, 30 . rmCIRP increased TNF-α release from cultured RAW 264.7 cells in a dose-and time-dependent manner ( Fig. 2a,b) . rmCIRP also dose-dependently induced the release of another proinflammatory cytokine, HMGB1 (Fig. 2c) . In vivo, administration of rmCIRP to healthy rats increased serum TNF-α, interleukin-6 (IL-6) and HMGB1 levels and induced liver injury, as assessed by increased levels of the organ injury markers aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (Supplementary Fig. 4 ).
To rule out a contribution from LPS in the inflammatory response to rmCIRP, we found that incubation with polymyxin B, an LPS-binding antibiotic, did not interfere with rmCIRP-induced production of TNF-α, whereas heat treatment reduced the activity of rmCIRP (Fig. 2d) . In contrast, polymyxin B inhibited LPS-induced TNF-α release by 84%, whereas heat treatment on LPS only slightly attenuated the amount of TNF-α released in response to LPS (Fig. 2d) . To further avoid LPS contamination in the preparation of recombinant proteins, we obtained the expressed and purified recombinant human CIRP (rhCIRP) from human HEK293 cells. rhCIRP had comparable activity to rmCIRP in dose-dependently stimulating TNF-α release from differentiated human THP-1 cells ( Fig. 2e) and primary human peripheral blood mononuclear cells (PBMCs) (Fig. 2f) . Thus, CIRP-induced cytokine activation is conserved between rodents and humans and is not due to LPS contamination.
HMGB1 can also stimulate TNF-α release 31 . We analyzed the relationship between CIRP and HMGB1 in stimulating TNF-α release by applying neutralizing antisera to each. We generated antisera to CIRP that effectively inhibited rmCIRP-induced TNF-α production in RAW 264.7 cells ( Supplementary Fig. 3c,d) . Preincubation of THP-1 cells with antisera to HMGB1 (ref. 32) reduced rmCIRP-induced TNF-α release nonsignificantly by 31%, whereas preincubation with antisera to CIRP resulted in a 70% reduction ( Fig. 2g) . Conversely, preincubation of THP-1 cells with antisera to CIRP resulted in only a 17% (nonsignificant) reduction of TNF-α release induced by rmH-MGB1 ( Fig. 2g) . In addition, rmCIRP, rmHMGB1 and rmCIRP plus rmHMGB1 induced TNF-α levels of 0.8, 0.6 and 1.6 ng ml −1 , respectively ( Fig. 2g) . Taken together, these results indicate that CIRP and HMGB1 additively stimulate TNF-α release from macrophages.
Neutralization of CIRP attenuates hemorrhage and sepsis
We next determined whether extracellular CIRP has a role in mediating inflammatory responses during hemorrhage. Administration of neutralizing antisera to CIRP during fluid resuscitation to hemorrhaged rats significantly reduced serum and hepatic levels of TNF-α and IL-6 as compared to hemorrhaged rats given control IgG (Fig. 3a) . Serum AST and ALT, as well as liver myeloperoxidase activity, which is indicative of neutrophil accumulation, were significantly reduced in the group administered the antisera to CIRP (Fig. 3b) . The survival rate in the rats administered the antisera to CIRP was significantly higher than that in the groups administered control IgG or vehicle at npg 10 d after hemorrhage (85% compared to 38% and 43%, respectively; Fig. 3c ). In concordance with antisera-mediated blockade of CIRP, the survival rate of Cirbp −/− mice was significantly higher than that of wild-type mice at 72 h after hemorrhage (56% compared to 11%, respectively; Fig. 3d ). We also observed a notable increase in serum TNF-α ( Fig. 3e) and HMGB1 ( Fig. 3f ) levels in wild-type mice at 4 h after hemorrhage, which was considerably reduced in Cirbp −/− mice (Fig. 3e) . These findings suggest that CIRP and HMGB1 both contribute to inflammation and mortality after shock. We then extended the study of the proinflammatory activity of CIRP to sepsis. We examined CIRP expression in rats subjected to cecal ligation and puncture (CLP), an established animal model of polymicrobial sepsis 33 . At 20 h after CLP, serum levels of CIRP were increased by 3.4-fold as compared to sham-operated controls (Fig. 4a) . Similarly, mRNA and protein levels of CIRP in the liver were also increased by 2.4-fold and 4.0-fold, respectively, at 20 h after CLP (Fig. 4b,c) . We also assessed the effect of LPS on CIRP expression and release in vitro. The mRNA and protein expression of CIRP in isolated rat primary peritoneal macrophages were increased after exposure to LPS for 6 and 24 h, respectively ( Fig. 4d,e) . CIRP protein was also detectable in the conditioned medium after 6 h of exposure to LPS (Fig. 4e) . We then examined whether other inflammatory mediators induce CIRP release. Incubation of RAW 264.7 cells with rmHMGB1 and rmTNF-α for 24 h did not induce CIRP release into the medium, whereas CIRP protein was detectable in the medium from cells exposed to LPS (Fig. 4f) . To assess whether extracellular npg CIRP contributes to mortality in sepsis, we administered neutralizing antisera to CIRP to septic animals 5 h after CLP. The 10-d survival rate of septic rats significantly increased from 39% to 78% in rats treated with antisera to CIRP (Fig. 4g) . Thus, CIRP also contributes to mortality in sepsis.
CIRP induces inflammatory responses through TLR4
We then determined which cell surface receptors are bound by extracellular CIRP. We examined three major PRRs that are known to mediate inflammatory responses: RAGE (also called AGER), TLR2 and TLR4 (refs. [8] [9] [10] . By comparing the differences in response to rmCIRP between macrophages from wild-type mice and mice deficient in each receptor, we found that only TLR4-deficient macrophages lost the response to rmCIRP (in terms of TNF-α induction), whereas RAGE-and TLR2-deficient macrophages maintained similar responses as wild-type macrophages (Fig. 5a) . To confirm the requirement of TLR4 in mediating CIRP activity, we injected rmCIRP into wild-type and Tlr4 −/− mice. Similar to rats, wild-type mice exhibited an increase in the levels of serum proinflammatory cytokines (TNF-α, IL-6 and HMGB1) and organ injury markers (AST and ALT) in a dose-dependent manner in response to rmCIRP injection (Fig. 5b,c) , which were diminished in Tlr4 −/− mice (Fig. 5b,c) . We then performed surface plasmon resonance (SPR) analysis to validate the physical interaction between CIRP and the receptors. TLR4 often binds to MD2 as a co-receptor to form the TLR4-MD2 complex 34 . We used the recombinant proteins derived from the human coding sequence for SPR analysis. rhCIRP bound to rhTLR4, rhMD2 and the rhTLR4-MD2 complex with apparent dissociation constants (K d ) of 6.17 × 10 −7 , 3.02 × 10 −7 and 2.39 × 10 −7 M, respectively (Table 1 and Supplementary Fig. 5 ). We also examined the binding of rhMD2 to rhTLR4 as a positive control and obtained an apparent K d of 5.37 × 10 −8 M, which is similar to the K d of 6.29 × 10 −8 M that was reported in a recent study 35 . Notably, rhCIRP had a K d in the nanomolar range in terms of binding to RAGE and TLR2 ( Table 1 and Supplementary Fig. 5) ; however, the biological importance of this remains to be determined. To determine the region of CIRP that bound to MD2, we synthesized 32 oligopeptides (15-mer) covering the entire human CIRP sequence and performed a series of SPR analyses. Three oligopeptides, residues 101-115, 106-120 and 111-125, bound to rhMD2 with high affinity ( Fig. 5d and Supplementary Fig. 6 ).
DISCUSSION
Intracellular CIRP is currently thought to stabilize specific mRNAs and facilitate translation for a survival advantage when cells are under stress 36, 37 . In this study, we provide several lines of evidence that extracellular CIRP is also a DAMP.
We demonstrated that CIRP translocates from the nucleus to the cytoplasm after exposure to hypoxia. Translocation of CIRP has also been observed in other cell types, including fibroblasts and epithelial cells, after exposure to UV irradiation, osmotic shock, heat shock or endoplasmic reticulum stresses 38, 39 . Methylation of arginine residues in the RGG domain of CIRP after environmental stress 38 and phosphorylation in the C-terminal region in response to UV irradiation 39 have been postulated to regulate the exit of CIRP from the nucleus. We also observed the release of CIRP into conditioned medium in response to hypoxia or LPS. A number of noncanonical pathways have been proposed for the release of 'leaderless' proteins, including microvesicle shedding, exocytosis of secretory lysosomes and active transport 27 . In addition, an alternative model of leaderless IL-1β secretion has been proposed that involves the formation of multivesicular bodies containing exosomes with entrapped IL-1β and fusion of these multivesicular bodies with the plasma membrane to release Representative sensorgrams of analyte interactions are shown in Supplementary  Figure 5 from two to three independent experiments.
npg the exosomes 40 . Although we demonstrated that CIRP can be released through the lysosomal secretion, other mechanisms responsible for CIRP release require further investigation. Identification of the TLR4-mediated proinflammatory activity of CIRP is consistent with previous studies showing that TLR4 has a major role in mediating inflammation and organ injury in hemorrhaged 41 and septic animals 42 . TLR4 can also recognize several endogenous molecules, including HMGB1, heat shock proteins, hyaluronic acid and fibronectin, when they are released from stressed, damaged or dying cells or from degradation of the extracellular matrix [43] [44] [45] [46] . Although many DAMPs serve as ligands of the TLR4-MD2 complex, some molecules may bind to the different sites of the TLR4-MD2 complex and work additively in stimulating proinflammatory cytokine production in macrophages, as we have demonstrated here through the relationship between CIRP and HMGB1. As indicated by SPR analysis, HMGB1 binds to the TLR4-MD2 complex with a K d of 1.5 × 10 −6 M 47 , which is comparable to that of CIRP (K d = 2.39 × 10 −7 M). HMGB1 has been shown to bind to MD2 with a K d of 8 × 10 −9 M but to not bind to TLR4 (ref. 48 ), whereas we found here that CIRP can bind to both MD2 and TLR4 individually. Additional mapping of the subdomains of CIRP that interact with TLR4, MD2 and the TLR4-MD2 complex will help ascertain how CIRP binds to and activates these receptors. Of note, the K d values of LPS to TLR4 and MD2 are 1.41 × 10 −5 and 2.33 × 10 −6 M, respectively 49 . In addition to the binding of the TLR4-MD2 complex, we also observed that CIRP can bind to TLR2 and RAGE, which fits its character as a chaperone protein to interact with different types of proteins.
Discovery of CIRP as an inflammatory mediator and DAMP not only advances our understanding of additional proinflammatory mediators but will also help in the development of new therapeutic strategies. We demonstrated that CIRP can be actively released, despite the fact that leaderless proteins can be leaked out by passive modes, such as necrosis 50 . In support of our findings, a recent study reported the involvement of CIRP in activating the nuclear factor-κB (NF-κB) pathway and regulating IL-1β expression in cultured fibroblasts 51 . As neutralizing antisera to CIRP attenuate inflammatory responses and improve the survival of hemorrhaged and septic animals, CIRP may be targeted therapeutically to reduce morbidity and mortality in individuals with hemorrhage and sepsis.
METHODS
Methods and any associated references are available in the online version of the paper. 
